{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:44:40Z","timestamp":1760237080370,"version":"build-2065373602"},"reference-count":48,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI125623"],"award-info":[{"award-number":["AI125623"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Based on a live attenuated Yersinia pestis KIM10(pCD1Ap) strain (Pgm\u2212, pPCP1\u2212), we attempted to engineer its lipid A species to achieve improvement of immunogenicity and safety. A mutant strain designated as YPS19(pCD1Ap), mainly synthesizing the hexa-acylated lipid A, and another mutant strain designated as YPS20(pCD1Ap), synthesizing 1-dephosphalated hexa-acylated lipid A (detoxified lipid A), presented relatively low virulence in comparison to KIM10(pCD1Ap) by intramuscular (i.m.) or subcutaneous (s.c.) administration. The i.m. administration with either the KIM10(pCD1Ap) or YPS19(pCD1Ap) strain afforded significant protection against bubonic and pneumonic plague compared to the s.c. administration, while administration with completely attenuated YPS20(pCD1Ap) strain failed to afford significant protection. Antibody analysis showed that i.m. administration induced balanced Th1 and Th2 responses but s.c. administration stimulated Th2-biased responses. Safety evaluation showed that YPS19(pCD1Ap) was relatively safer than its parent KIM10(pCD1Ap) in Hfe\u2212\/\u2212 mice manifesting iron overload in tissues, which also did not impair its protection. Therefore, the immune activity of hexa-acylated lipid A can be harnessed for rationally designing bacteria-derived vaccines.<\/jats:p>","DOI":"10.3390\/vaccines8010095","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T08:59:47Z","timestamp":1582275587000},"page":"95","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Protection and Safety Evaluation of Live Constructions Derived from the Pgm\u2212 and pPCP1\u2212 Yersinia pestis Strain"],"prefix":"10.3390","volume":"8","author":[{"given":"Xiuran","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0071-6987","authenticated-orcid":false,"given":"Wei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"ref_1","first-page":"631","article-title":"Immunity in plague. Acquisitions supplied by 30 years of work ont the \u201cPasteurella pestis EV\u201d (Girard and Robic) strain","volume":"52","author":"Girard","year":"1963","journal-title":"Biol. Med. (Paris)"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1586\/erv.09.129","article-title":"Prospects for new plague vaccines","volume":"8","author":"Feodorova","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/iai.8.6.876-881.1973","article-title":"Pathogenicity and immunogenic efficacy of a live attentuated plaque vaccine in vervet monkeys","volume":"8","author":"Hallett","year":"1973","journal-title":"Infect. Immun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/infdis\/129.Supplement_1.S13","article-title":"Plague immunization. I. Past and present trends","volume":"129","author":"Meyer","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1093\/infdis\/129.Supplement_1.S85","article-title":"Live, attenuated Yersinia pestis vaccine: Virulent in nonhuman primates, harmless to guinea pigs","volume":"129","author":"Meyer","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"Russell","year":"1995","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1128\/iai.43.3.895-900.1984","article-title":"In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae","volume":"43","author":"Une","year":"1984","journal-title":"Infect. Immun."},{"key":"ref_9","unstructured":"CDC (1995). Update: Human plague India 1994. CDC Morb. Mortal. Wkly. Rep., 43, 722\u2013723."},{"key":"ref_10","first-page":"787","article-title":"Agarwal GS Isolation and identification of Yersinia pestis responsible for the recent plague outbreaks in India","volume":"71","year":"1996","journal-title":"Curr. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMc1010939","article-title":"Investigation of a Researcher\u2019s Death Due to Septicemic Plague","volume":"364","author":"Frank","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/infdis\/jis433","article-title":"Hereditary hemochromatosis restores the virulence of plague vaccine strains","volume":"206","author":"Quenee","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_13","first-page":"653","article-title":"Effectiveness of live or killed plague vaccines in man","volume":"42","author":"Meyer","year":"1970","journal-title":"Bull. World Health Organ."},{"key":"ref_14","unstructured":"WHO Expert Committee on Plague (1970). W.H.O. Technical Report Series 447:16, WHO."},{"key":"ref_15","unstructured":"Yazdanpanah, Y. (2018, January 23). Efficacy trials of Plague Vaccines: Endpoints, trial design, site selection. Proceedings of the WHO Workshop 2018, Paris, France."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/647986","article-title":"Tetraacylated lipopolysaccharide of Yersinia pestis can inhibit multiple Toll-like receptor-mediated signaling pathways in human dendritic cells","volume":"200","author":"Telepnev","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ni1386","article-title":"Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response","volume":"7","author":"Montminy","year":"2006","journal-title":"Nat. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/CVI.00336-09","article-title":"Immunomodulatory effects of Yersinia pestis lipopolysaccharides on human macrophages","volume":"17","author":"Matsuura","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.vaccine.2011.01.099","article-title":"A live attenuated strain of Yersinia pestis KIM as a vaccine against plague","volume":"29","author":"Sun","year":"2011","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/IAI.01403-12","article-title":"Pathogenicity of Yersinia pestis synthesis of 1-dephosphorylated lipid A","volume":"81","author":"Sun","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0264-410X(97)00254-5","article-title":"Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system","volume":"16","author":"Thoelen","year":"1998","journal-title":"Vaccine"},{"key":"ref_23","first-page":"2654","article-title":"Isolation of a nontoxic lipid A fraction containing tumor regression activity","volume":"41","author":"Takayama","year":"1981","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/00222615-25-3-197","article-title":"Lipopolysaccharide-Induced Non-Specific Resistance to Systemic Escherichia-Coli Infection in Mice","volume":"25","author":"Vuopiovarkila","year":"1988","journal-title":"J. Med. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.1137195","article-title":"A plasminogen-activating protease specifically controls the development of primary pneumonic plague","volume":"315","author":"Lathem","year":"2007","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/mpat.1997.0154","article-title":"Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain CO92","volume":"23","author":"Welkos","year":"1997","journal-title":"Microb. Pathog."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.1439793","article-title":"A surface protease and the invasive character of plague","volume":"258","author":"Sodeinde","year":"1992","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.chom.2014.03.005","article-title":"The Pla protease of Yersinia pestis degrades fas ligand to manipulate host cell death and inflammation","volume":"15","author":"Caulfield","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Smiley, S.T., Szaba, F.M., Kummer, L.W., Duso, D.K., and Lin, J.S. (2019). Yersinia pestis Pla protein thwarts T cell defense against plague. Infect. Immun.","DOI":"10.1128\/IAI.00126-19"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1073\/pnas.0509544103","article-title":"Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague","volume":"103","author":"Sebbane","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1099\/mic.0.029124-0","article-title":"Deletion of Braun lipoprotein gene (lpp) and curing of plasmid pPCP1 dramatically alter the virulence of Yersinia pestis CO92 in a mouse model of pneumonic plague","volume":"155","author":"Agar","year":"2009","journal-title":"Microbiology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/iai.51.2.445-454.1986","article-title":"Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins","volume":"51","author":"Straley","year":"1986","journal-title":"Infect. Immun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"12909","DOI":"10.1073\/pnas.0502849102","article-title":"Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus","volume":"102","author":"Pujol","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.120163297","article-title":"One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products","volume":"97","author":"Datsenko","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1128\/AEM.00940-08","article-title":"Highly efficient method for introducing successive multiple scarless gene deletions and markerless gene insertions into the Yersinia pestis chromosome","volume":"74","author":"Sun","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood-2001-11-0037","article-title":"Regulation of iron absorption in Hfe mutant mice","volume":"100","author":"Ajioka","year":"2002","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sun, W., Roland, K.L., Branger, C.G., Kuang, X., and Curtiss, R. (2009). The role of relA and spoT in Yersinia pestis KIM5 pathogenicity. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006720"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/IAI.00105-08","article-title":"Yersinia pestis caf1 variants and the limits of plague vaccine protection","volume":"76","author":"Quenee","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1038\/s41598-017-05810-2","article-title":"Iron overload exacerbates age-associated cardiac hypertrophy in a mouse model of hemochromatosis","volume":"7","author":"Sukumaran","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1128\/CVI.05591-11","article-title":"Establishment of a Swiss Webster mouse model of pneumonic plague to meet essential data elements under the animal rule","volume":"19","author":"Fellows","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.1998.58.793","article-title":"Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice","volume":"58","author":"Anderson","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1126\/science.273.5273.367","article-title":"Role of the Yersinia pestis hemin storage (hms) locus in the transmission of plague by fleas","volume":"273","author":"Hinnebusch","year":"1996","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1462-2920.2007.01554.x","article-title":"Insights into Yersinia pestis biofilm development: Topology and co-interaction of Hms inner membrane proteins involved in exopolysaccharide production","volume":"10","author":"Bobrov","year":"2008","journal-title":"Environ. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1128\/IAI.01236-09","article-title":"The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague","volume":"78","author":"Fetherston","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1016\/j.vaccine.2007.08.055","article-title":"A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs","volume":"25","author":"Feodorova","year":"2007","journal-title":"Vaccine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.01529-06","article-title":"Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection","volume":"75","author":"Philipovskiy","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1128\/IAI.00273-09","article-title":"D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague","volume":"77","author":"Szaba","year":"2009","journal-title":"Infect. Immun."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/1\/95\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:59:36Z","timestamp":1760173176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/1\/95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["vaccines8010095"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8010095","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2020,2,21]]}}}